Investors in Finance

KPN Ventures is a corporate venture arm of KPN that aims to partner with innovative technology companies, providing access to capital, expertise, network, and customer channels. It focuses on early growth-stage European companies in networking technology, the internet of things, smart home, digital healthcare, cyber security, mobile and video (OTT) services, cloud computing, data, and analytics. It began operation on June 1, 2015, with its headquarters in Rotterdam in the Netherlands.

Elro Vision Ltd provides Cash backed BG Bank Guarantee and SBLC Standby Letter of Credit is with Top Rated Banks. Our globally integrated team is an essential component of our international Finance, We provide advice and finance on all types of financing, including structured trade, commodities, general trade, export, import, supply chain, and corporate financing. Elro Vision Ltd is dedicated to achieving successful results for our all clients.

ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing the private financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large.

Winton Ventures is the corporate venture arm of Winton Group that invests in companies that operate in the cybersecurity, energy and environment, and data science-driven healthcare sectors. It leverages Winton’s extensive experience and in-house expertise in data science to make better investment decisions and to support actively its portfolio companies. It began operation in 2015, with its headquarters in London in the United Kingdom.

Boehringer Ingelheim Venture Fund (BIVF) invests in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research. BIVF is searching for significant enhancements in patient care through pioneering science and its clinical translation by building long-term relationships with scientists and entrepreneurs. BIVF’s focus is to target unprecedented therapeutic concepts addressing high medical needs in immuno-oncology, regenerative medicine, infectious diseases and digital health. These may include novel platform technologies to address so far undruggable targets, new generation vaccines and/or new biological entities, such as oncolytic virotherapy.

ATPI, one of the most exciting and dynamic brands in the travel industry. An independent global company, with over 100 offices worldwide. Our range of complementary in-house services is rare. And our thorough understanding of travel management is matched by our expertise in planning and producing major events. Today's travellers have complex demands – both for speed and efficiency and for cost-effective solutions.

Elevator Ventures is the Corporate Venture Capital entity of Raiffeisen Bank International (RBI) headquartered in Vienna. Its primary focus is on early stage and growth investments in Fintech and related enabling technologies in Central and Eastern Europe. In the role of a leading growth partner for Fintech's in CEE, Elevator Ventures leverages RBI Group`s expertise, network and corporate strength in order to help promising scaleups expand across this dynamic region and beyond.

The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world. Bertelsmann Investments (BI) is a global venture capital firm partnering with top entrepreneurs and investors worldwide to drive growth and value creation. Managing a diverse portfolio of over 200 companies and including 10 unicorns.

Partech is a global investment firm with offices in San Francisco, Paris, Berlin, and Dakar. They bring together capital, operational experience, and strategic support for entrepreneurs at seed, venture, and growth stages across multiple continents, with over a $1.5B investment capacity. Investments range from $200K to $50M in a wide range of technologies and businesses for enterprises and consumers, from software, digital brands, and services, to hardware and deep tech across all major industries. Companies backed by Partech have completed more than 20 initial public offerings and more than 50 strategic exits above $100M.

The National Security Strategic Investment Fund is the British Government’s corporate venturing arm for dual-use advanced technologies. It is a joint initiative between HM Government and the British Business Bank. NSSIF invests commercially in advanced technology firms, alongside other investors, supporting long-term equity investment – ‘patient capital’ – and harnesses the Government’s unique technology expertise. Its objectives include accelerating the adoption of HMG’s future national security and defense capabilities and the development of the UK’s dual-use technology ecosystem.

Big Issue Invest is the UK's first 'social merchant bank,' by social entrepreneurs, for social entrepreneurs. As a social enterprise ourselves, we understand how good businesses can achieve great things." Nigel Kershaw - Chair, The Big Issue Group.

Brose Ventures invests globally in early-stage startups to shape the future of mobility. Our focus spans across electrified and connected vehicles, sustainability, micro-mobility, AI & ML, sensor technologies, advanced materials, new production technologies and a wide range of other disruptive technologies and business models. Our direct relationship with Brose means access to deep automotive expertise and the network of a €6bn revenue tier-1 supplier. We introduce our companies to Brose as a potential customer or strategic partner for joint development and commercialisation projects.